Wolverine Trading
PTCT icon

Wolverine Trading’s PTC Therapeutics PTCT Stock Holding History

Wolverine Trading’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$388K Buy
+6,400
New +$333K ﹤0.01% 4012
2023
Q2 		– Sell
-5,200
Closed -$254K – 4792
2023
Q1 		$254K Buy
+5,200
New +$238K ﹤0.01% 3185
2022
Q4 		– Sell
-4,800
Closed -$242K – 4821
2022
Q3 		$242K Buy
+4,800
New +$235K ﹤0.01% 3376
2020
Q4 		– Sell
-14,000
Closed -$662K – 5332
2020
Q3 		$662K Sell
14,000
-2,200
-14% -$108K ﹤0.01% 2507
2020
Q2 		$820K Buy
16,200
+8,200
+103% +$403K ﹤0.01% 2213
2020
Q1 		$340K Sell
8,000
-23,500
-75% -$1.18M ﹤0.01% 3087
2019
Q4 		$1.5M Sell
31,500
-30,500
-49% -$1.3M ﹤0.01% 2056
2019
Q3 		$2.15M Buy
62,000
+29,600
+91% +$1.29M 0.01% 1388
2019
Q2 		$1.46M Buy
32,400
+16,000
+98% +$632K ﹤0.01% 1737
2019
Q1 		$617K Sell
16,400
-6,400
-28% -$215K ﹤0.01% 2537
2018
Q4 		$730K Sell
22,800
-29,700
-57% -$1.07M ﹤0.01% 2273
2018
Q3 		$2.47M Buy
52,500
+18,800
+56% +$778K 0.01% 1483
2018
Q2 		$912K Hold
33,700
– – ﹤0.01% 2357
2018
Q1 		$912K Sell
33,700
-9,200
-21% -$233K ﹤0.01% 2357
2017
Q4 		$716K Sell
42,900
-28,900
-40% -$489K ﹤0.01% 2588
2017
Q3 		$1.44M Buy
71,800
+7,000
+11% +$137K 0.01% 1582
2017
Q2 		$1.2M Buy
+64,800
New +$873K 0.01% 1596

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's PTCT Position: Q3 2025 in Review

Wolverine Trading sold out of PTC Therapeutics (PTCT) in Q3 2025, closing a stake of 10,836 shares — an estimated $564K sold.

Wolverine Trading first reported a position in PTCT in Q2 2017 and held it in 11 quarters. The position peaked at $871K in Q1 2019. 293 funds tracked by Wall St. Rank hold PTCT as of Q3 2025.

  • Wolverine Trading reported no remaining PTC Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Wolverine Trading sold 10,836 PTC Therapeutics shares in Q3 2025, an estimated $564K.
  • Wolverine Trading first reported a position in PTC Therapeutics in Q2 2017 and held it in 11 quarters.
  • Wolverine Trading's PTC Therapeutics position peaked at $871K in Q1 2019.
  • 293 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.